Protagonist Therapeutics (PTGX) PT Raised to $72 at BMO Capital Post ANTHEM/ICONIC Data
Tweet Send to a Friend
BMO Capital analyst Evan David Seigerman raised the price target on Protagonist Therapeutics (NASDAQ: PTGX) to $72.00 (from $62.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
